NICE Rejects Cannabis Oil for Extreme Epilepsy

NICE Rejects Cannabis Oil for Extreme Epilepsy The nationwide Institute for Health and Care Excellence (SWEET) decided against recommending cannabis oil cannabidiol (Epidyolex, GW Pharma) with clobazam for the treatment of two kinds of serious treatment resistant epilepsy, Dravet, and Lennox-Gastaut syndromes. However, it was said by it wished to use the producer to handle …

NICE Rejects Cannabis Oil for Extreme Epilepsy Read More »